Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by Garp1on Feb 26, 2016 9:35am

107 Views

Post# 24598029

RE:RE:broker 15 UBS

To be more precise, The UBS broker has been used to sell 100 shares each time TH started to rally during and at the end of the trading day. This is a very cheap way of maintaining the price down and tends to suggest a potential takeover strategy (friendly or not) the bid price can be set to show a maximum premium based on the last 5 trading days. Look at UBS trades today, to see if the trend is maintained.

Bullboard Posts

Geologica Resource: Polymetallic upside at a depressed price